e-learning
resources
Vienna 2012
Monday, 03.09.2012
Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alternative multiple breath washout outcomes for clinical trials in cystic fibrosis
F. Ratjen, J. Salazar, R. Jensen, R. Amin, P. Gustafsson, S. Stanojevic, P. Subbarao (Toronto, Canada; Skoevde, Sweden)
Source:
Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Session:
Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Session type:
Oral Presentation
Number:
1845
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Ratjen, J. Salazar, R. Jensen, R. Amin, P. Gustafsson, S. Stanojevic, P. Subbarao (Toronto, Canada; Skoevde, Sweden). Alternative multiple breath washout outcomes for clinical trials in cystic fibrosis. Eur Respir J 2012; 40: Suppl. 56, 1845
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Multiple breath washout in bronchiectasis clinical trials: is it feasible?
Source: ERJ Open Res, 6 (4) 00363-2019; 10.1183/23120541.00363-2019
Year: 2020
The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Change in functional lung MRI and multiple breath washout outcomes over one year in children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
End-points and biomarkers for clinical trials in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 104-115
Year: 2014
The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008
The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials
Source: ERJ Open Res, 4 (1) 00094-2017; 10.1183/23120541.00094-2017
Year: 2018
Evaluation of SnIII parameters as outcome measures of multiple breath washout (MBW) in preschool children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Nitrogen multiple breath washout test for infants with cystic fibrosis
Source: Eur Respir J, 52 (2) 1800015; 10.1183/13993003.00015-2018
Year: 2018
Characterisation of leaks during multiple breath washout and their influence on test results
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations
Source: Eur Respir J , 49 (4) 1601102; DOI: 10.1183/13993003.01102-2016
Year: 2017
Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?
Source: Eur Respir J 2011; 37: 757-759
Year: 2011
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Nitrogen multiple breath washout indices as potentially prognostic markers in idiopathic pulmonary fibrosis
Source: International Congress 2017 – Lung function testing
Year: 2017
Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis.
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Clinical response to elexacaftor/tezacaftor/ivacaftor for cystic fibrosis patients in a compassionate use setting
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Heterogeneity of treatment response in bronchiectasis clinical trials
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Multiple breath washout: measuring early manifestations of lung pathology
Source: Breathe, 17 (3) 210016; 10.1183/20734735.0016-2021
Year: 2021
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept